
July 25 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:
SOBI ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION APPROVES DOPTELET® (AVATROMBOPAG) FOR THE TREATMENT OF THROMBOCYTOPENIA IN PEDIATRIC PATIENTS ONE YEAR AND OLDER WITH PERSISTENT OR CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)